Literature DB >> 3586973

[Cost of the individual treatment of Trypanosoma brucei gambiense trypanosomiasis in a focus of infection in Niari (Congo)].

J P Gouteux, P Bansimba, F Noireau, J L Frezil.   

Abstract

A survey carried out on 101 patients has shown that the treatment of human sleeping sickness, theoretically free, is relatively costly. The average total cost amount to 58,000 F C.F.A., ranging from free treatment up to much as 110,000 F C.F.A. This high cost in part explains the cases where treatment is refused, something which has frequently been observed in the Congo. It would therefore be desirable for patients, who are significant epidemiological reservoirs of T. b. gambiense, to receive economic aid.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3586973

Source DB:  PubMed          Journal:  Med Trop (Mars)        ISSN: 0025-682X


  4 in total

1.  Quantifying the burden of rhodesiense sleeping sickness in Urambo District, Tanzania.

Authors:  Lucas E Matemba; Eric M Fèvre; Stafford N Kibona; Kim Picozzi; Sarah Cleaveland; Alexandra P Shaw; Susan C Welburn
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

Review 2.  A literature review of economic evaluations for a neglected tropical disease: human African trypanosomiasis ("sleeping sickness").

Authors:  C Simone Sutherland; Joshua Yukich; Ron Goeree; Fabrizio Tediosi
Journal:  PLoS Negl Trop Dis       Date:  2015-02-05

3.  The burden of human African trypanosomiasis.

Authors:  Eric M Fèvre; Beatrix V Wissmann; Susan C Welburn; Pascal Lutumba
Journal:  PLoS Negl Trop Dis       Date:  2008-12-23

4.  Human African trypanosomiasis in a rural community, Democratic Republic of Congo.

Authors:  Pascal Lutumba; Eric Makieya; Alexandra Shaw; Filip Meheus; Marleen Boelaert
Journal:  Emerg Infect Dis       Date:  2007-02       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.